@razorgenomics.com
Razor Genomics is a life science company that researches and develops novel tests for the diagnosis of lung cancer located in Brisbane.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Razor Genomics is a brand that specializes in offering molecular stratification tests for patients with IA-IIA non-squamous non-small cell lung cancer (NSCLC). With the aim of identifying patients who may be at low or high risk of recurrence, their flagship product, RiskReveal, provides a better understanding of which patients may benefit from adjuvant therapy. Each year, around 40,000 patients are diagnosed with early-stage NSCLC, and despite complete surgical resection, up to 45% of them will not survive past five years.
RiskReveal offers a solution by analyzing the molecular signature of a patient's tumor tissue to stratify their risk for recurrence, enabling healthcare professionals to make informed treatment decisions following surgery. The effectiveness of RiskReveal has been validated in two independent cohorts, involving close to 1400 patients, outperforming NCCN criteria in identifying patients at high risk for mortality. In fact, test-identified high-risk patients who received adjuvant platinum doublet chemotherapy showed a 97.
0% 5-year freedom from recurrence compared to 72. 4% for those who did not receive chemotherapy. Razor Genomics is committed to providing accessible and affordable testing for all patients, offering a Patient Assistance Program to assist with the costs of their test.
With their innovative approach, Razor Genomics aims to optimize treatment decisions and improve patient outcomes
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories